Pentoxifylline versus prednisolone for severe alcoholic hepatitis: A randomized controlled trial

doi:10.3748/wjg.15.1613

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 13

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8864)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

628

HTML

7772

Figures (1-2)

234

Tables (1-5)

230

Sum=8864

Apr 7, 2009 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (107)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Articles

World J Gastroenterol. Apr 7, 2009; 15(13): 1613-1619
Published online Apr 7, 2009. doi: 10.3748/wjg.15.1613

Open in New Tab Full Size Figure Download Figure

Figure 1 Survival curves (Kaplan-Meier life table analysis) of patients receiving pentoxifylline (group I) as compared to patients receiving prednisolone (group II), at the end of 3 mo of therapy.

Open in New Tab Full Size Figure Download Figure

Figure 2 Summary of trial design and follow-up.

Citation: De BK, Gangopadhyay S, Dutta D, Baksi SD, Pani A, Ghosh P. Pentoxifylline versus prednisolone for severe alcoholic hepatitis: A randomized controlled trial. World J Gastroenterol 2009; 15(13): 1613-1619
URL: https://www.wjgnet.com/1007-9327/full/v15/i13/1613.htm
DOI: https://dx.doi.org/10.3748/wjg.15.1613